{"DataElement":{"publicId":"3271391","version":"1","preferredName":"Breast Carcinoma Primary Lesion Type","preferredDefinition":"Name that is descriptive of a primary breast carcinoma lesion.","longName":"PRIM_TUM_LES_TP","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"3271035","version":"1","preferredName":"Breast Carcinoma Primary Neoplasm","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002_Occurring first in time or sequence; original. (American Heritage Dictionary)_(TOO-mer) An abnormal mass of tissue that results from excessive cell division. Tumors perform no useful body function. They may be benign (not cancerous) or malignant (cancerous).","longName":"2475941v1.0:2226941v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2475941","version":"1","preferredName":"Breast Carcinoma","preferredDefinition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit.  Breast carcinoma may affect both females and males.  It is the most common malignant tumor and the leading cause of carcinoma death in women.  Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation.  The widespread use of mammography has contributed in the detection of very early cancerous lesions (less than 2mm in diameter).  The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular).  Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route.  The most common site of lymph node involvment is the axilla.  Breast carcinomas infrequently occur in males (particularly elderly individuals and patients with Klinefelter's syndrome).  The therapy of breat carcinoma includes surgery, radiation therapy, hormonal therapy and chemotherapy, depending on the type and extend of the disease. --2002","longName":"C4872","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Carcinoma","conceptCode":"C4872","definition":"A carcinoma arising from the breast, most commonly the terminal ductal-lobular unit. It is the most common malignant tumor in females. Risk factors include country of birth, family history, menstrual and reproductive history, fibrocystic disease and epithelial hyperplasia, exogenous estrogens, contraceptive agents, and ionizing radiation. The vast majority of breast carcinomas are adenocarcinomas (ductal or lobular). Breast carcinoma spreads by direct invasion, by the lymphatic route, and by the blood vessel route. The most common site of lymph node involvement is the axilla.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"11C95199-159B-5C1E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-19","modifiedBy":"ONEDATA","dateModified":"2006-04-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2226941","version":"1","preferredName":"Primary Neoplasm","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):(TOO-mer) An abnormal mass of tissue that results from excessive cell division. Tumors perform no useful body function. They may be benign (not cancerous) or malignant (cancerous).","longName":"C25251:CL053268","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"CL053268","definition":"(TOO-mer) An abnormal mass of tissue that results from excessive cell division. Tumors perform no useful body function. They may be benign (not cancerous) or malignant (cancerous).","evsSource":"NCI_META_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F6C1590C-74C9-60E6-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-10","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-05-10","modifiedBy":"ONEDATA","dateModified":"2005-05-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008549","version":"1","preferredName":"Involvement and Extent of Disease","preferredDefinition":"indication of the presence and extent of disease.","longName":"INV_AND_EXT_OF_DZ","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22AA815-A017-5261-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACCDDB6A-128B-4F88-E040-BB89AD43550E","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3271386","version":"1","preferredName":"Lesion Type","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part._Type; a subdivision of a particular kind of thing.","longName":"3271386v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Architectural Distortion","valueDescription":"Architectural Distortion","ValueMeaning":{"publicId":"3271390","version":"1","preferredName":"Architectural Distortion","longName":"3271390","preferredDefinition":"A morphologic finding indicating alteration of the shape/pattern of tissue components.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Architectural Distortion","conceptCode":"C82986","definition":"A morphologic finding indicating alteration of the shape/pattern of tissue components.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD63232-B11F-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACD63232-B138-12DE-E040-BB89AD4341CB","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","deletedIndicator":"No"},{"value":"Calcification(s)","valueDescription":"Calcification","ValueMeaning":{"publicId":"3243767","version":"1","preferredName":"Calcification","longName":"3243767","preferredDefinition":"Deposition of calcium in the tissues.  It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Calcification","conceptCode":"C3672","definition":"Deposition of calcium in the tissues. It may be the result of a metabolic disorder or long-standing infection, or it may be associated with the presence of cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A5998517-0646-18CA-E040-BB89AD434D5D","latestVersionIndicator":"Yes","beginDate":"2011-06-13","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-06-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACD63232-B14C-12DE-E040-BB89AD4341CB","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","deletedIndicator":"No"},{"value":"Mass","valueDescription":"Mass","ValueMeaning":{"publicId":"3194160","version":"1","preferredName":"Mass","longName":"3194160","preferredDefinition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mass","conceptCode":"C34808","definition":"A benign or malignant pathologic structure in any part of the body, resulting from a neoplastic accumulation of cells, inflammatory cells, or cystic changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D7998CF-FD46-3339-E040-BB89AD436014","latestVersionIndicator":"Yes","beginDate":"2011-03-01","endDate":null,"createdBy":"ALAIS","dateCreated":"2011-03-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"ACD63232-B161-12DE-E040-BB89AD4341CB","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","deletedIndicator":"No"},{"value":"MR Non-Mass-Like Enhancement","valueDescription":"Defined Imaging Enhancement Description","ValueMeaning":{"publicId":"3271388","version":"1","preferredName":"Defined Imaging Enhancement Description","longName":"3271388","preferredDefinition":"The textual representation for how an image is enhanced either physically or electronically.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Defined Imaging Enhancement Description","conceptCode":"C93771","definition":"The textual representation for how an image is enhanced either physically or electronically.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD63232-B0F9-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DCD8EC7C-4565-6D0C-E040-BB89AD435CE2","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-05-16","modifiedBy":"ONEDATA","dateModified":"2013-05-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3271385","version":"1","preferredName":"Lesion Type","preferredDefinition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.:Type; a subdivision of a particular kind of thing.","longName":"C3824:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lesion","conceptCode":"C3824","definition":"A localized pathological or traumatic structural change, damage, deformity, or discontinuity of tissue, organ, or body part.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD63232-B0D0-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"ONEDATA","dateModified":"2011-09-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"ACD63232-B0E1-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"REEVESD","dateModified":"2013-05-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461589","version":"1","longName":"Imaging Elements","context":"NCIP"}]},{"publicId":"3886754","version":"1","longName":"Imaging Elements","context":"BOLD","ClassificationSchemeItems":[{"publicId":"3902139","version":"1","longName":"Imaging","context":"BOLD"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Lesion Type","type":"Preferred Question Text","description":"Lesion Type","url":null,"context":"BOLD"}],"origin":"BOLD:Breast Oncology Local Disease Initiative","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"ACD63232-B16C-12DE-E040-BB89AD4341CB","latestVersionIndicator":"Yes","beginDate":"2011-09-13","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-09-13","modifiedBy":"REEVESD","dateModified":"2016-05-17","changeDescription":"Curated for BOLD Imaging data collection","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}